CrowdStrike is upgraded to "Buy" after a 30% drawdown amid sector-wide software weakness. CRWD's robust fundamentals include 22% YoY revenue growth, record free cash flow, and strong ARR acceleration via Falcon Flex. Valuation now appears attractive, with a fair value estimate near $464 based on $6.18 out-year EPS and a 3x PEG.
Agentic AI has caused quite the panic in some of the software names out there. Undoubtedly, some software companies are definitely vulnerable as AI agents look to become more capable.
CRWD shares slide nearly 22% in 3 months as slowing revenue growth, rising costs and rich valuation pressure investor confidence.
In the closing of the recent trading day, CrowdStrike Holdings (CRWD) stood at $421.73, denoting a -3.9% move from the preceding trading day.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Recently, Zacks.com users have been paying close attention to CrowdStrike (CRWD). This makes it worthwhile to examine what the stock has in store.
CrowdStrike stock (NASDAQ: CRWD) has decreased by over 20% from its 52-week peak of $566, currently trading at approximately $440. The reasons?
CrowdStrike Holdings Inc. NASDAQ: CRWD stock has declined nearly 8% year-to-date amid broader market pressures. The general slump in technology stocks has become sharply focused on software stocks, including some of the top cybersecurity names.
CRWD is boosting Next-Gen SIEM with Charlotte AI, driving record ARR wins and helping customers replace legacy SIEM platforms.
In the latest trading session, CrowdStrike Holdings (CRWD) closed at $476.66, marking a +1.78% move from the previous day.
A U.S. judge recently dismissed a shareholder lawsuit that accused cybersecurity company CrowdStrike Holdings Inc.
CrowdStrike (CRWD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.